Innovax-ND-H5

Authorised

This medicine is authorised for use in the European Union

Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. 

Product details

• Name of medicine:
  Innovax-ND-H5
• Active substance:
  Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5
• International non-proprietary name (INN) or common name:
  Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5

Pharmacotherapeutic group

• Live viral vaccines
• Domestic fowl

Authorisation details

• EMA product number:
  EMEA/V/C/006362

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Innovax-ND-H5

Reference Number: EMA/CVMP/165069/2024